ACORAMIDIS vs ADALIMUMAB-AACF: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ACORAMIDIS vs ADALIMUMAB-AACF: Safety Overview
| Metric | ACORAMIDIS | ADALIMUMAB-AACF |
|---|---|---|
| Total FAERS Reports | 234 | 140 |
| Deaths Reported | 8 | 1 |
| Death Rate | 3.4% | 0.7% |
| Hospitalizations | 40 | 63 |
| Average Patient Age | 79.6 yrs | 54.6 yrs |
| % Female Patients | 18.3% | 60.5% |
| FDA Approval Date | Nov 22, 2024 | N/A |
| Manufacturer | BridgeBio Pharma, Inc. | Fresenius Kabi USA, LLC |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |